Kross Reports 80% YoY Revenue Growth in Q2 FY27, PAT Reaches Rs.19.69 Crore

Kross reported revenue of Rs 419.4 crore and profit after tax (PAT) of Rs 33.16 crore for H1 FY27, with management expecting stronger volumes in the second half of the financial year.
Trailer and Component Businesses Support Growth
Kross's revenue mix remained balanced between its trailer and component businesses during the quarter. The trailer segment contributed 49% of Q2 revenue, while components accounted for the remaining 51%. Exports also continued to contribute to the component business, representing around 7.5% to 8% of its total component revenue.
The company has also started commercial production of extruded axle beams. The facility is currently operating at 65% to 80% capacity utilisation, providing scope to increase output as demand develops.
Financial Performance, Expansion Plans and Outlook
- Q2 FY27 revenue: Revenue from operations stood at Rs 235 crore, registering 80% year-on-year growth.
- Q2 EBITDA: EBITDA came in at Rs 30.6 crore, translating to an operating margin of approximately 13%.
- Q2 PAT: Profit after tax reached Rs 19.69 crore.
- H1 FY27 performance: Revenue stood at Rs 419.4 crore, while PAT was Rs 33.16 crore for the first half of the financial year.
- Revenue mix: The trailer segment contributed 49% of Q2 revenue, with the component business accounting for 51%.
- Exports: International sales accounted for approximately 7.5% to 8% of the component business.
- Extruded axle beams: Commercial production has commenced, with capacity utilisation currently ranging between 65% and 80%.
- Second-half outlook: Management expects Q3 and Q4 volumes to remain strong, noting that second-half volumes have historically been around 20% higher than those in the first half.
- Backward integration project: Kross is investing Rs 170 crore in a seamless tube project. The funding plan includes Rs 110 crore in term loans and Rs 60 crore from internal accruals.
- Margin outlook: Higher steel and consumable costs are putting pressure on margins in the near term. Management expects price revisions by original equipment manufacturers (OEMs) to help support profitability in the coming quarters.
What to Watch Next
Market participants will monitor whether Kross maintains its revenue momentum in the second half of FY27, improves capacity utilisation at its extruded axle beam facility and manages rising input costs. Progress on the Rs 170 crore seamless tube project and the timing of OEM price revisions will also be important factors influencing margins and profitability.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News

Bajaj Nivesh Reports 9.7% Revenue Growth in Q2 FY27, Net Profit Rises 9.8%
Bajaj Nivesh Limited has reported its financial results for the quarter and half year ended September 30, 2026. The company recorded revenue from operations of Rs.297.36 crore in Q2 FY27, up 9.7% year-on-year (YoY). Net profit for the quarter stood at Rs.293.27 crore, while earnings per share increased to Rs.256.61 from Rs.233.69 in the corresponding quarter last year.

Balkrishna Industries Signs Strategic Partnership with Pirelli for Premium Car Tyres in India
Balkrishna Industries Limited (BKT) has signed a strategic agreement with Pirelli to expand its presence in India's premium passenger car tyre market. Under the agreement, BKT will produce up to 800,000 Pirelli-branded premium car tyres by 2030. Production will take place at one of BKT's newly constructed plants, equipped with advanced technology and designed to meet Pirelli's quality standards. The agreement also provides for a potential 50-50 joint venture to build a new production plant for high-value car tyres for domestic and international markets. The partnership aims to help both companies benefit from the expected growth in India's premium car tyre market.

Corona Remedies Receives ANVISA GMP Certification for Two Manufacturing Facilities
Corona Remedies Limited has received Good Manufacturing Practice (GMP) Compliance Certification from Brazil’s Health Regulatory Agency, ANVISA, for its Oral Solid Dosage (OSD) manufacturing facility and Hormone manufacturing facility, both located at Bhayla, Ahmedabad, Gujarat. The company disclosed the development to BSE Limited and the National Stock Exchange of India Limited on October 22, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The certification may support the company's efforts to expand its presence in international pharmaceutical markets, subject to applicable regulatory requirements.